Fumiyasu Igata

发表

Feasibility, utility, and safety of transbronchial cryobiopsy for interstitial lung diseases in Japan

M. Fujita, K. Nabeshima, Y. Kinoshita, 2021, Multidisciplinary respiratory medicine.

Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial

M. Fujita, K. Takayama, J. Uchino, 2018, Investigational New Drugs.

Impact of Results of TTF-1 Immunostaining on Efficacy of Platinum-Doublet Chemotherapy in Japanese Patients with Nonsquamous Non-Small-Cell Lung Cancer

H. Arima, M. Hamasaki, H. Inoue, 2022, Journal of clinical medicine.

A case of crescentic glomerulonephritis induced by afatinib for lung adenocarcinoma

Koji Takahashi, K. Masutani, N. Uesugi, 2022, CEN Case Reports.

Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report

M. Fujita, H. Inoue, T. Harada, 2021, Thoracic cancer.

Clinical Features of Lung Cancer in Japanese Patients Aged Under 50.

M. Fujita, J. Uchino, A. Iwasaki, 2016, Asian Pacific journal of cancer prevention : APJCP.

Mediastinal Seminoma with an Elevated Level of Serum Angiotensin-converting Enzyme.

K. Nabeshima, H. Ishii, H. Kushima, 2015, Internal medicine.

THE PSYCHOLOGICAL DISTRESS THAT IDIOPATHIC PULMONARY FIBROSIS PATIENTS AND CAREGIVERS EXPERIENCE. THE INVISIBLE INJURY THAT ADDS COMPLEXITY TO MANAGEMENT AND TREATMENT

Matsumoto, P. Reynolds, J. Hsu, 2019, Respirology (Carlton South. Print).

Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

M. Fujita, T. Harada, Takato Ikeda, 2023, AntiCancer Research.